The fluorescent immunoassay market was valued at US$ 2,578.66 million in 2021 and is projected to reach US$ 3,778.78 million by 2028; it is expected to grow at a CAGR of 5.6% from 2021 to 2028.
Fluorescent immunoassays are simply a different type of immunoassay. The critical variable is the biochemical technique used to detect the binding of the "detector" antibody and the analyte molecule. Fluorescent immunoassay is a sensitive technique that can measure many compounds, including drugs, hormones, and proteins; identify antibodies; and quantify antigens such as viral particles and possibly bacteria. The fluorescence detection system includes higher sensitivity detection of the analyte, simplified reagents, and simpler assay designs. Several breakthroughs have been made in recent years that have enabled a fluorescence-based immunoassay system at the point of care. Several technical improvements have recently occurred that have allowed a susceptible immunoassay system to implement. These include the availability of narrow-wavelength, low-cost light sources, newer, more stable fluorophores with extensive Stokes shifts, stable solid-state light detectors, and microprocessors to process and analyze the data from each test. When a fluorescence detection system is connected to a lateral flow assay and combined with a powerful yet inexpensive analyzer, the result is improved assay performance.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Fluorescent Immunoassay Market: Strategic Insights
Market Size Value in US$ 2,578.66 Million in 2021 Market Size Value by US$ 3,778.78 Million by 2028 Growth rate CAGR of 5.6% from 2021 to 2028 Forecast Period 2021-2028 Base Year 2021
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Fluorescent Immunoassay Market: Strategic Insights
| Market Size Value in | US$ 2,578.66 Million in 2021 |
| Market Size Value by | US$ 3,778.78 Million by 2028 |
| Growth rate | CAGR of 5.6% from 2021 to 2028 |
| Forecast Period | 2021-2028 |
| Base Year | 2021 |
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
The scope of the global fluorescent immunoassay market includes product type, application, end user, and geography. The market for fluorescent immunoassay is analyzed based on regions such as North America, Europe, Asia Pacific, the Middle East & Africa, and South & Central America. The report offers insights and in-depth analysis of the fluorescent immunoassay market, emphasizing on various parameters such as market trends, technological advancements, market dynamics, and competitive landscape analysis of leading market players across the globe.
Lucrative Regions for Fluorescent Immunoassay Market
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Market Insights
Growing Prevalence of Chronic Diseases across the World.
Growing Prevalence of Chronic Diseases across the World.
Chronic diseases and conditions are on the rise worldwide. The need for costly chronic care is increasing, placing significant demands on healthcare systems. According to the Centers for Disease Control and Prevention (CDC), an estimated 150 million Americans had one or more chronic conditions as of 2016. According to the World Health Organization (WHO), the prevalence of chronic diseases was projected to increase by 57% in 2020. According to the National Center for Biotechnology Information (NCBI), chronic kidney disease (CKD) is the 14th leading cause of death worldwide and is responsible for 1.2 million deaths each year. Early detection and treatment are crucial, as progressive CKD is associated with unfortunate clinical consequences, including end-stage kidney disease (ESKD), cardiovascular diseases, and increased mortality. The diagnosis, prognosis, and control of chronic kidney disease are based on understanding the glomerular filtration rate (GFR). Cystatin-C is a better GFR marker than the commonly used creatinine. The fluorescence lateral flow immunoassay was developed and optimized to estimate the cystatin C value to calculate the glomerular filtration rate.
The COVID-19 pandemic highlighted the need for rapid and accurate nucleic acid detection at the point of care. Fluorescence-based quantitative reverse transcription PCR (RT-qPCR) has high sensitivity and specificity. In addition, a maximum of people infected with SARS-CoV-2 develop mild or no symptoms. There is, therefore, an urgent need to develop rapid, simple, and high-throughput assays for the detection of nucleic acids. A standard fluorescence immunoassay system is a multiparametric, random access system that provides accurate and reliable diagnostic results. It is a system capable of performing qualitative and quantitative analyses of infections, respiratory diseases, and chronic diseases. A cut-off index provides a good reference point for medical decision-making. Thus, rising incidence of COVID-19 cases and growing chronic diseases are responsible for the global fluorescent immunoassay market growth.
Product Type - Based Insights
Based on product type, the market is segmented into ELISA, rapid lateral flow immunoassay, and others. In 2021, the ELISA segment accounted for the largest share of the market. ELISA is a plate-based test technique for detecting and measuring soluble molecules such as peptides, proteins, antibodies, and hormones. The growth of this segment is attributed to the significant use of immunoassay tests to diagnose cancer, infectious illnesses, and other chronic problems. The same segment is likely to register the highest CAGR in the global fluorescent immunoassay market during the forecast period.
Global Fluorescent Immunoassay Market, by Application – 2021 & 2028
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Request discounts available for Start-Ups & Universities
Application - Based Insights
Based on application, the global fluorescent immunoassay market is segmented into infectious diseases, oncology, cardiovascular diseases, and others. The infectious diseases segment held the largest share of the market in 2021, and the same segment is anticipated to register the highest CAGR in the market during the forecast period.
End User – Based Insights
In terms of end user, the global fluorescent immunoassay market is segmented into hospitals & clinics, diagnostic centers, pharmaceutical & biotechnology companies, academic & research institutes, and others. The hospitals & clinics segment held the largest share of the market in 2021, and the same segment is anticipated to register the highest CAGR in the market during the forecast period.
The COVID-19 pandemic has become the most significant challenge across the world. This challenge was frightening, especially in developing countries across the globe, as it reduced imports due to disruptions in global trade. To date, no definitive treatment against COVID-19 has been established. Hence, the lack of definitive therapy offers significant opportunities for the global fluorescent immunoassay market. In the long run, the fluorescent immunoassay market would have significant growth prospects as many market players had received emergency use authorization for their newly developed tests. In May 2020, ERBA Diagnostics Mannheim GmbH (Germany) launched its immunoassay-based kit—ErbaLisa COVID-19 ELISA kits to detect IgG and IgM antibodies against SARS-CoV-2. In addition, researchers developed portable devices, reagents, and standards suitable for home use. Therefore, all such developments would add up to the proliferating future demand for fluorescent immunoassays.
Companies commonly adopt product launches and expansion strategies to expand their footprint worldwide and meet the growing demand. The market players commonly adopt these strategies in order to expand their product portfolio.
The market players operating in the global fluorescent immunoassay market adopted the strategy of product innovation to cater to changing customer demand worldwide, which also permits the players to maintain their brand name globally.
- In June 2021, F. Hoffmann-La Roche Ltd. announced that it had launched a high-throughput SARS-CoV-2 antigen test as an aid in the diagnosis of SARS-CoV-2 infections. The laboratory-based Elecsys SARS-CoV-2 Antigen test had earlier received a CE mark and has recently obtained the import license from CDSCO.
- In May 2021, BD Multitest 6-Color TBNK Reagent with BD Trucount Tubes was launched to help clinicians determine the risks of Intubation with Mechanical Ventilation and mortality in COVID-19 patients, aiding in-patient management decisions. The BD Multitest 6-Color TBNK Reagent with optional BD Trucount Tubes was licensed by Health Canada as a 6-color direct immunofluorescence reagent for use with a suitably equipped BD flow cytometer to identify and determine the percentages and absolute counts of T, B, and natural killer (NK) cells, as well as the CD4 and CD8 subpopulations of T cells in peripheral blood. The BD Multitest 6-Color TBNK Reagent with BD Trucount Tubes can be used with the BD FACS Loader and the BD FACS Universal Loader.
- In May 2021, Ortho Clinical Diagnostics announced that its quantitative COVID-19 IgG antibody test achieved a CE Mark. Ortho’s VITROS Anti-SARS-CoV-2 IgG Quantitative Antibody test is traceable to the WHO International Standard for anti-SARS-CoV-2 IgG antibodies, which is developed to facilitate the standardization of SARS-CoV-2 serological methods.
- In December 2020, Beckman Coulter announced the launch of a new test that addressed the three main barriers currently facing schools, businesses, hospitals, and communities with the rollout of mass COVID-19 testing. The new Access SARS-CoV-2 Antigen assay provided a high-quality, high-throughput COVID-19 test with the volume, workflow, and scalable flexibility needed to help fight the COVID-19 pandemic. The Access SARS-CoV-2 Antigen assay was offered to healthcare providers at US$ 4, making reliable and frequent mass testing affordable.
Fluorescent Immunoassay – Market Segmentation
The global fluorescent immunoassay market is segmented based on product type, application, and end user. Based on product type, the fluorescent immunoassay market is further segmented into ELISA, rapid lateral flow immunoassay, and others. In terms of application, the fluorescent immunoassay market is further segmented into infectious diseases, oncology, cardiovascular diseases, and others. Based on end user, the fluorescent immunoassay market is segmented into hospitals & clinics, diagnostic centers, pharmaceutical & biotechnology companies, academic & research institutes, and others. By geography, the global fluorescent immunoassay market is segmented into North America (the US, Canada, and Mexico), Europe (France, Germany, the UK, Spain, Italy, and the Rest of Europe), Asia Pacific (China, India, Japan, Australia, South Korea, and the Rest of APAC), the Middle East & Africa (Saudi Arabia, the UAE, South Africa, and the Rest of MEA), and South & Central America (Brazil, Argentina, and the Rest of South & Central America).
Company Profiles
- Abbott
- BD
- bioMerieux SA
- F. Hoffman-La Roche Ltd.
- Siemens AG
- Sysmex Corp.
- Thermo Fisher Scientific Inc.
- Quidel Corp.
- Ortho Clinical Diagnostics Holdings plc
- Danaher
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Product Type, Application, and End User
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States
Frequently Asked Questions
The ELISA segment dominated the global fluorescent immunoassay market and held the largest market share of 56.12% in 2021.
The infectious diseases segment dominated the global fluorescent immunoassay market and held the largest market share of 54.39% in 2021.
The hospitals & clinics segment dominated the global fluorescent immunoassay market and held the largest market share of 43.16% in 2021.
The fluorescent immunoassay market majorly consists of the players such as Abbott, BD, bioMerieux SA, F. Hoffman-La Roche Ltd., Siemens AG, Sysmex Corp., Thermo Fisher Scientific Inc., Quidel Corp., Ortho Clinical Diagnostics Holdings plc, Danaher and among others.
The factors that are driving the growth of the market are the growing prevalence of chronic diseases and increasing demand for cell therapies are expected to boost the growth of the global fluorescent immunoassay market.
Fluorescence immunoassay is a sensitive technique that is used in the measurement of many compounds, including drugs, hormones, and proteins; in the identification of antibodies; and in the quantification of antigens such as viral particles and, potentially, bacteria. The fluorescence detection system includes higher sensitivity detection of the analyte, simplified reagents, and simpler assay designs. A modern fluorescent-based immunoassay uses as the detection reagent a fluorescent compound that absorbs light or energy (excitation energy) at a specific wavelength and then emits light or energy at a different wavelength.
1. Introduction
1.1 Study Scope
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Fluorescent Immunoassay Market – By Product Type
1.3.2 Fluorescent Immunoassay Market – By Application
1.3.3 Fluorescent Immunoassay Market – By End User
1.3.4 Global Fluorescent Immunoassay Market – By Geography
2. Fluorescent Immunoassay Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Fluorescent Immunoassay Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America – PEST Analysis
4.2.2 Europe – PEST Analysis
4.2.3 Asia Pacific – PEST Analysis
4.2.4 Middle East & Africa – PEST Analysis
4.2.5 South & Central America– PEST Analysis
4.3 Expert Opinions
5. Fluorescent Immunoassay Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Growing Prevalence of Chronic Diseases
5.1.2 Increasing Demand for Cell Therapies
5.2 Market Restraints
5.2.1 Disadvantages of Fluorescent Immunoassays
5.3 Market Opportunities
5.3.1 Extensive Usage in Cancer Diagnostics
5.4 Future Trends
5.4.1 Increase in Development of Fluorescent Dyes and Instruments
5.5 Impact Analysis
6. Fluorescent Immunoassay Market – Global Analysis
6.1 Global Fluorescent Immunoassay Marker Revenue Forecast and Analysis
6.1.1 Global Fluorescent Immunoassay Market, By Geography - Forecast And Analysis
6.1.2 Global Fluorescent Immunoassay Market – Market Potential Analysis, By Region
6.1.3 Market Share Analysis of Fluorescent Immunoassay Market
6.2 Company Analysis
6.2.1 Market Positioning of Key Players
6.2.2 Comparative Company Analysis
6.2.3 Growth Strategy Analysis
6.2.4 Performance Of Key Players
6.2.4.1 F. Hoffman-La Roche Ltd.
6.2.4.2 Thermo Fisher Scientific Inc.
7. Fluorescent Immunoassay Market Analysis and Forecasts to 2028 Product Type
7.1 Overview
7.2 Global Fluorescent Immunoassay Market Share by Product Type - 2021 & 2028 (%)
7.3 ELISA
7.3.1 Overview
7.3.2 ELISA: Fluorescent Immunoassay Market Revenue and Forecast to 2028 (USD Million)
7.4 Rapid Lateral Flow Immunoassay
7.4.1 Overview
7.4.2 Rapid Lateral Flow Immunoassay: Fluorescent Immunoassay Market Revenue and Forecast to 2028 (USD Million)
7.5 Others
7.5.1 Overview
7.5.2 Others: Fluorescent Immunoassay Market Revenue and Forecast to 2028 (USD Million)
8. Fluorescent Immunoassay Market Analysis – By Application
8.1 Overview
8.2 Global Fluorescent Immunoassay Market Share by Application - 2021 & 2028 (%)
8.3 Infectious Diseases
8.3.1 Overview
8.3.2 Infectious Diseases: Fluorescent Immunoassay Market Revenue and Forecast to 2028 (USD Million)
8.4 Oncology
8.4.1 Overview
8.4.2 Oncology: Fluorescent Immunoassay Market Revenue and Forecast to 2028 (USD Million)
8.5 Cardiovascular Disease
8.5.1 Overview
8.5.2 Cardiovascular Disease: Fluorescent Immunoassay Market Revenue and Forecast to 2028 (USD Million)
8.6 Others
8.6.1 Overview
8.6.2 Others: Fluorescent Immunoassay Market Revenue and Forecast to 2028 (USD Million)
9. Fluorescent Immunoassay Market – By End User
9.1 Overview
9.2 Global Fluorescent Immunoassay Market Share by End User - 2021 & 2028 (%)
9.3 Hospitals & Clinics
9.3.1 Overview
9.3.2 Hospitals & Clinics: Fluorescent Immunoassay Market Revenue and Forecast to 2028 (USD Million)
9.4 Diagnostic Centers
9.4.1 Overview
9.4.2 Diagnostic Centers: Fluorescent Immunoassay Market Revenue and Forecast to 2028 (USD Million)
9.5 Pharmaceutical & Biotechnology Companies
9.5.1 Overview
9.5.2 Pharmaceutical & Biotechnology Companies: Fluorescent Immunoassay Market Revenue and Forecast to 2028 (USD Million)
9.6 Academic & Research Institutes
9.6.1 Overview
9.6.2 Academic & Research Institutes: Fluorescent Immunoassay Market Revenue and Forecast to 2028 (USD Million)
9.7 Others
9.7.1 Overview
9.7.2 Others: Fluorescent Immunoassay Market Revenue and Forecast to 2028 (USD Million)
10. Fluorescent Immunoassay Market Analysis and Forecasts To 2028 Geographical Analysis
10.1 North America: Fluorescent Immunoassay Market
10.1.1 Overview
10.1.2 North America Fluorescent Immunoassay Market Revenue and Forecasts to 2028 (USD Million)
10.1.3 North America: Fluorescent Immunoassay Market, by Product Type – Revenue and Forecast to 2028 (USD Million)
10.1.4 North America: Fluorescent Immunoassay Market, by Application – Revenue and Forecast to 2028 (USD Million)
10.1.5 North America: Fluorescent Immunoassay Market, by End User – Revenue and Forecast to 2028 (USD Million)
10.1.6 North America Fluorescent Immunoassay Market Revenue and Forecasts to 2028, By Country (%)
10.1.6.1 US: Fluorescent Immunoassay Market – Revenue and Forecast to 2028 (USD million)
10.1.6.1.1 Overview
10.1.6.1.2 US: Fluorescent Immunoassay Market Revenue and Forecasts to 2028 (USD Million)
10.1.6.1.3 US: Fluorescent Immunoassay Market, by Product Type – Revenue and Forecast to 2028 (USD Million)
10.1.6.1.4 US: Fluorescent Immunoassay Market, by Application – Revenue and Forecast to 2028 (USD Million)
10.1.6.1.5 US: Fluorescent Immunoassay Market, by End User – Revenue and Forecast to 2028 (USD Million)
10.1.6.2 Canada: Fluorescent Immunoassay Market – Revenue and Forecast to 2028 (USD million)
10.1.6.2.1 Overview
10.1.6.2.2 Canada: Fluorescent Immunoassay Market Revenue and Forecasts to 2028 (USD Million)
10.1.6.2.3 Canada: Fluorescent Immunoassay Market, by Product Type – Revenue and Forecast to 2028 (USD Million)
10.1.6.2.4 Canada: Fluorescent Immunoassay Market, by Application – Revenue and Forecast to 2028 (USD Million)
10.1.6.2.5 Canada: Fluorescent Immunoassay Market, by End User – Revenue and Forecast to 2028 (USD Million)
10.1.6.3 Mexico: Fluorescent Immunoassay Market – Revenue and Forecast to 2028 (USD Million)
10.1.6.3.1 Overview
10.1.6.3.2 Mexico: Fluorescent Immunoassay Market Revenue and Forecasts to 2028 (USD Million)
10.1.6.3.3 Mexico: Fluorescent Immunoassay Market, by Product Type – Revenue and Forecast to 2028 (USD Million)
10.1.6.3.4 Mexico: Fluorescent Immunoassay Market, by Application – Revenue and Forecast to 2028 (USD Million)
10.1.6.3.5 Mexico: Fluorescent Immunoassay Market, by End User – Revenue and Forecast to 2028 (USD Million)
10.2 Europe: Fluorescent Immunoassay Market
10.2.1 Overview
10.2.2 Europe Fluorescent Immunoassay Market Revenue and Forecasts to 2028 (USD Million)
10.2.2.1.1 Europe: Fluorescent Immunoassay Market, by Product Type – Revenue and Forecast to 2028 (USD Million)
10.2.2.1.2 Europe: Fluorescent Immunoassay Market, by Application – Revenue and Forecast to 2028 (USD Million)
10.2.2.1.3 Europe: Fluorescent Immunoassay Market, by End User – Revenue and Forecast to 2028 (USD Million)
10.2.3 Europe Fluorescent Immunoassay Market Revenue and Forecasts to 2028, By Country (%)
10.2.3.1 Germany: Fluorescent Immunoassay Market – Revenue and Forecast to 2028 (USD million)
10.2.3.1.1 Overview
10.2.3.1.2 Germany: Fluorescent Immunoassay Market Revenue and Forecasts to 2028 (USD Million)
10.2.3.1.3 Germany: Fluorescent Immunoassay Market, by Product Type – Revenue and Forecast to 2028 (USD Million)
10.2.3.1.4 Germany: Fluorescent Immunoassay Market, by Application – Revenue and Forecast to 2028 (USD Million)
10.2.3.1.5 Germany: Fluorescent Immunoassay Market, by End User – Revenue and Forecast to 2028 (USD Million)
10.2.3.2 UK: Fluorescent Immunoassay Market – Revenue and Forecast to 2028 (USD million)
10.2.3.2.1 Overview
10.2.3.2.2 UK: Fluorescent Immunoassay Market Revenue and Forecasts to 2028 (USD Million)
10.2.3.2.3 UK: Fluorescent Immunoassay Market, by Product Type – Revenue and Forecast to 2028 (USD Million)
10.2.3.2.4 UK: Fluorescent Immunoassay Market, by Application – Revenue and Forecast to 2028 (USD Million)
10.2.3.2.5 UK: Fluorescent Immunoassay Market, by End User – Revenue and Forecast to 2028 (USD Million)
10.2.3.3 France: Fluorescent Immunoassay Market – Revenue and Forecast to 2028 (USD million)
10.2.3.3.1 Overview
10.2.3.3.2 France: Fluorescent Immunoassay Market Revenue and Forecasts to 2028 (USD Million)
10.2.3.3.3 France: Fluorescent Immunoassay Market, by Product Type – Revenue and Forecast to 2028 (USD Million)
10.2.3.3.4 France: Fluorescent Immunoassay Market, by Application – Revenue and Forecast to 2028 (USD Million)
10.2.3.3.5 France: Fluorescent Immunoassay Market, by End User – Revenue and Forecast to 2028 (USD Million)
10.2.3.4 Italy: Fluorescent Immunoassay Market – Revenue and Forecast to 2028 (USD million)
10.2.3.4.1 Overview
10.2.3.4.2 Italy: Fluorescent Immunoassay Market Revenue and Forecasts to 2028 (USD Million)
10.2.3.4.3 Italy: Fluorescent Immunoassay Market, by Product Type – Revenue and Forecast to 2028 (USD Million)
10.2.3.4.4 Italy: Fluorescent Immunoassay Market, by Application – Revenue and Forecast to 2028 (USD Million)
10.2.3.4.5 Italy: Fluorescent Immunoassay Market, by End User – Revenue and Forecast to 2028 (USD Million)
10.2.3.5 Spain: Fluorescent Immunoassay Market – Revenue and Forecast to 2028 (USD million)
10.2.3.5.1 Overview
10.2.3.5.2 Spain: Fluorescent Immunoassay Market Revenue and Forecasts to 2028 (USD Million)
10.2.3.5.3 Spain: Fluorescent Immunoassay Market, by Product Type – Revenue and Forecast to 2028 (USD Million)
10.2.3.5.4 Spain: Fluorescent Immunoassay Market, by Application – Revenue and Forecast to 2028 (USD Million)
10.2.3.5.5 Spain: Fluorescent Immunoassay Market, by End User – Revenue and Forecast to 2028 (USD Million)
10.2.3.6 Rest of Europe: Fluorescent Immunoassay Market – Revenue and Forecast to 2028 (USD million)
10.2.3.6.1 Overview
10.2.3.6.2 Rest of Europe: Fluorescent Immunoassay Market Revenue and Forecasts to 2028 (USD Million)
10.2.3.6.3 Rest of Europe: Fluorescent Immunoassay Market, by Application – Revenue and Forecast to 2028 (USD Million)
10.2.3.6.4 Rest of Europe: Fluorescent Immunoassay Market, by Application – Revenue and Forecast to 2028 (USD Million)
10.2.3.6.5 Rest of Europe: Fluorescent Immunoassay Market, by End User – Revenue and Forecast to 2028 (USD Million)
10.3 Asia Pacific: Fluorescent Immunoassay Market
10.3.1 Overview
10.3.2 Asia Pacific: Fluorescent Immunoassay Market - Revenue and Forecast to 2028 (USD Million)
10.3.3 Asia-Pacific: Fluorescent Immunoassay Market, by Product Type – Revenue and Forecast to 2028 (USD Million)
10.3.4 Asia-Pacific: Fluorescent Immunoassay Market, by Application – Revenue and Forecast to 2028 (USD Million)
10.3.5 Asia-Pacific: Fluorescent Immunoassay Market, by End User – Revenue and Forecast to 2028 (USD Million)
10.3.6 Asia Pacific: Fluorescent Immunoassay Market, by Country, 2021 & 2028 (%)
10.3.6.1 China: Fluorescent Immunoassay Market – Revenue and Forecast to 2028 (USD Million)
10.3.6.1.1 China: Fluorescent Immunoassay Market – Revenue and Forecast to 2028 (USD Million)
10.3.6.1.2 China Fluorescent Immunoassay Market, by Product Type – Revenue and Forecast to 2028 (USD Million)
10.3.6.1.3 China: Fluorescent Immunoassay Market, by Application – Revenue and Forecast to 2028 (USD Million)
10.3.6.1.4 China: Fluorescent Immunoassay Market, by End User – Revenue and Forecast to 2028 (USD Million)
10.3.6.2 Japan: Fluorescent Immunoassay Market – Revenue and Forecast to 2028 (USD Million)
10.3.6.2.1 Japan: Fluorescent Immunoassay Market – Revenue and Forecast to 2028 (USD Million)
10.3.6.2.2 Japan: Fluorescent Immunoassay Market, by Product Type – Revenue and Forecast to 2028 (USD Million)
10.3.6.2.3 Japan: Fluorescent Immunoassay Market, by Application – Revenue and Forecast to 2028 (USD Million)
10.3.6.2.4 Japan: Fluorescent Immunoassay Market, by End User – Revenue and Forecast to 2028 (USD Million)
10.3.6.3 India: Fluorescent Immunoassay Market – Revenue and Forecast to 2028 (USD Million)
10.3.6.3.1 India: Fluorescent Immunoassay Market – Revenue and Forecast to 2028 (USD Million)
10.3.6.3.2 India: Fluorescent Immunoassay Market, by Product Type – Revenue and Forecast to 2028 (USD Million)
10.3.6.3.3 India: Fluorescent Immunoassay Market, by Application – Revenue and Forecast to 2028 (USD Million)
10.3.6.3.4 India: Fluorescent Immunoassay Market, by End User – Revenue and Forecast to 2028 (USD Million)
10.3.6.4 South Korea: Fluorescent Immunoassay Market – Revenue and Forecast to 2028 (USD Million)
10.3.6.4.1 South Korea: Fluorescent Immunoassay Market – Revenue and Forecast to 2028 (USD Million)
10.3.6.4.2 South Korea: Fluorescent Immunoassay Market, by Product Type – Revenue and Forecast to 2028 (USD Million)
10.3.6.4.3 South Korea: Fluorescent Immunoassay Market, by Application – Revenue and Forecast to 2028 (USD Million)
10.3.6.4.4 South Korea: Fluorescent Immunoassay Market, by End User – Revenue and Forecast to 2028 (USD Million)
10.3.6.5 Australia: Fluorescent Immunoassay Market – Revenue and Forecast to 2028 (USD Million)
10.3.6.5.1 Australia: Fluorescent Immunoassay Market – Revenue and Forecast to 2028 (USD Million)
10.3.6.5.2 Australia: Fluorescent Immunoassay Market, by Product Type – Revenue and Forecast to 2028 (USD Million)
10.3.6.5.3 Australia: Fluorescent Immunoassay Market, by Application – Revenue and Forecast to 2028 (USD Million)
10.3.6.5.4 Australia: Fluorescent Immunoassay Market, by End User – Revenue and Forecast to 2028 (USD Million)
10.3.6.6 Rest of Asia Pacific: Fluorescent Immunoassay Market – Revenue and Forecast to 2028 (USD Million)
10.3.6.6.1 Rest of Asia Pacific: Fluorescent Immunoassay Market – Revenue and Forecast to 2028 (USD Million)
10.3.6.6.2 Rest of Asia Pacific: Fluorescent Immunoassay Market, by Product Type – Revenue and Forecast to 2028 (USD Million)
10.3.6.6.3 Rest of Asia Pacific: Fluorescent Immunoassay Market, by Application – Revenue and Forecast to 2028 (USD Million)
10.3.6.6.4 Rest of Asia Pacific: Fluorescent Immunoassay Market, by End User – Revenue and Forecast to 2028 (USD Million)
10.4 Middle East & Africa: Fluorescent Immunoassay Market
10.4.1 Overview
10.4.2 Middle East & Africa: Fluorescent Immunoassay Market - Revenue and Forecast to 2028 (USD Million)
10.4.3 Middle East & Africa Fluorescent Immunoassay Market, by Product Type – Revenue and Forecast to 2028 (USD Million)
10.4.4 Middle East & Africa Fluorescent Immunoassay Market, by Application– Revenue and Forecast to 2028 (USD Million)
10.4.5 Middle East & Africa Fluorescent Immunoassay Market, by End User– Revenue and Forecast to 2028 (USD Million)
10.4.6 Middle East & Africa Fluorescent Immunoassay Market, by Country, 2021 & 2028 (%)
10.4.6.1 Saudi Arabia: Fluorescent Immunoassay Market – Revenue and Forecast to 2028 (USD Million)
10.4.6.1.1 Saudi Arabia: Fluorescent Immunoassay Market – Revenue and Forecast to 2028 (USD Million)
10.4.6.1.2 Saudi Arabia Fluorescent Immunoassay Market, by Product Type – Revenue and Forecast to 2028 (USD Million)
10.4.6.1.3 Saudi Arabia Fluorescent Immunoassay Market, by Application – Revenue and Forecast to 2028 (USD Million)
10.4.6.1.4 Saudi Arabia Fluorescent Immunoassay Market, by End User – Revenue and Forecast to 2028 (USD Million)
10.4.6.2 UAE: Fluorescent Immunoassay Market – Revenue and Forecast to 2028 (USD Million)
10.4.6.2.1 UAE: Fluorescent Immunoassay Market – Revenue and Forecast to 2028 (USD Million)
10.4.6.2.2 UAE: Fluorescent Immunoassay Market, by Product Type – Revenue and Forecast to 2028 (USD Million)
10.4.6.2.3 UAE: Fluorescent Immunoassay Market, by Application – Revenue and Forecast to 2028 (USD Million)
10.4.6.2.4 UAE: Fluorescent Immunoassay Market, by End User – Revenue and Forecast to 2028 (USD Million)
10.4.6.3 South Africa: Fluorescent Immunoassay Market – Revenue and Forecast to 2028 (USD Million)
10.4.6.3.1 South Africa: Fluorescent Immunoassay Market – Revenue and Forecast to 2028 (USD Million)
10.4.6.3.2 South Africa Fluorescent Immunoassay Market, by Product Type – Revenue and Forecast to 2028 (USD Million)
10.4.6.3.3 South Africa Fluorescent Immunoassay Market, by Application – Revenue and Forecast to 2028 (USD Million)
10.4.6.3.4 South Africa Fluorescent Immunoassay Market, by End User – Revenue and Forecast to 2028 (USD Million)
10.4.6.4 Rest of Middle East and Africa: Fluorescent Immunoassay Market – Revenue and Forecast to 2028 (USD Million)
10.4.6.4.1 Rest of Middle East and Africa: Fluorescent Immunoassay Market – Revenue and Forecast to 2028 (USD Million)
10.4.6.4.2 Rest of Middle East & Africa Fluorescent Immunoassay Market, by Product Type – Revenue and Forecast to 2028 (USD Million)
10.4.6.4.3 Rest of Middle East & Africa: Fluorescent Immunoassay Market, by Application – Revenue and Forecast to 2028 (USD Million)
10.4.6.4.4 Rest of Middle East & Africa: Fluorescent Immunoassay Market, by End User – Revenue and Forecast to 2028 (USD Million)
10.5 South and Central America: Fluorescent Immunoassay Market
10.5.1 Overview
10.5.2 South and Central America Fluorescent Immunoassay Market Revenue and Forecasts to 2028 (USD Million)
10.5.2.1.1 South and Central America: Fluorescent Immunoassay Market, by Product Type – Revenue and Forecast to 2028 (USD Million)
10.5.2.1.2 South and Central America: Fluorescent Immunoassay Market, by Application– Revenue and Forecast to 2028 (USD Million)
10.5.2.1.3 South and Central America: Fluorescent Immunoassay Market, by End User – Revenue and Forecast to 2028 (USD Million)
10.5.3 South and Central America Fluorescent Immunoassay Market Revenue and Forecasts to 2028, By Country (%)
10.5.3.1 Brazil: Fluorescent Immunoassay Market Revenue and Forecasts to 2028 (USD Million)
10.5.3.1.1 Overview
10.5.3.1.2 Brazil: Fluorescent Immunoassay Market Revenue and Forecasts to 2028 (USD Million)
10.5.3.1.3 Brazil: Fluorescent Immunoassay Market, by Product Type – Revenue and Forecast to 2028 (USD Million)
10.5.3.1.4 Brazil: Fluorescent Immunoassay Market, by Application – Revenue and Forecast to 2028 (USD Million)
10.5.3.1.5 Brazil: Fluorescent Immunoassay Market, by End User – Revenue and Forecast to 2028 (USD Million
10.5.3.2 Argentina Fluorescent Immunoassay Market Revenue and Forecasts to 2028 (USD Million)
10.5.3.2.1 Overview
10.5.3.2.2 Argentina Fluorescent Immunoassay Market Revenue and Forecasts to 2028 (USD Million)
10.5.3.2.3 Argentina: Fluorescent Immunoassay Market, by Product Type – Revenue and Forecast to 2028 (USD Million)
10.5.3.2.4 Argentina: Fluorescent Immunoassay Market, by Application – Revenue and Forecast to 2028 (USD Million)
10.5.3.3 Rest of South and Central America: Fluorescent Immunoassay Market– Revenue and Forecast to 2028 (USD Mn)
10.5.3.3.1 Overview
10.5.3.3.2 Rest of South and Central America: Fluorescent Immunoassay Market– Revenue and Forecast to 2028 (USD Mn)
10.5.3.3.3 Rest of South and Central America: Fluorescent Immunoassay Market, by Product Type – Revenue and Forecast to 2028 (USD Million)
10.5.3.3.4 Rest of South and Central America: Fluorescent Immunoassay Market, by Application – Revenue and Forecast to 2028 (USD Million)
10.5.3.3.5 Rest of South and Central America: Fluorescent Immunoassay Market, by End User – Revenue and Forecast to 2028 (USD Million)
11. Impact of COVID-19 Pandemic on Global Fluorescent Immunoassay Market
11.1 North America: Impact Assessment of COVID-19 Pandemic
11.2 Europe: Impact Assessment of COVID-19 Pandemic
11.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
11.4 Middle East & Africa: Impact Assessment of COVID-19 Pandemic
11.5 South & Central America: Impact Assessment of COVID-19 Pandemic
12. Industry Landscape
12.1 Overview
12.2 Growth Strategies in the Fluorescent Immunoassay Market (%)
12.3 Organic Developments
12.3.1 Overview
12.4 Inorganic Developments
12.4.1 Overview
13. Company Profiles
13.1 F. HOFFMANN-LA ROCHE LTD.
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 THERMO FISHER SCIENTIFIC INC.
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Abbott
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 BD
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Danaher
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 bioMerieux SA
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Sysmex Corporation
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Siemens AG
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Ortho Clinical Diagnostics Holdings plc
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 Quidel Corporation
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. Appendix
14.1 About The Insight Partners
14.2 Glossary of Terms
LIST OF TABLES
Table 1. US: Fluorescent Immunoassay Market, by Product Type – Revenue and Forecast to 2028 (USD Million)
Table 2. US: Fluorescent Immunoassay Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 3. US: Fluorescent Immunoassay Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 4. Canada: Fluorescent Immunoassay Market, by Product Type – Revenue and Forecast to 2028 (USD Million)
Table 5. Canada: Fluorescent Immunoassay Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 6. Canada: Fluorescent Immunoassay Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 7. Mexico: Fluorescent Immunoassay Market, by Product Type – Revenue and Forecast to 2028 (USD Million)
Table 8. Mexico: Fluorescent Immunoassay Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 9. Mexico: Fluorescent Immunoassay Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 10. Europe: Fluorescent Immunoassay Market, by Product Type – Revenue and Forecast to 2028 (USD Million)
Table 11. Europe: Fluorescent Immunoassay Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 12. Europe: Fluorescent Immunoassay Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 13. Germany: Fluorescent Immunoassay Market, by Product Type – Revenue and Forecast to 2028 (USD Million)
Table 14. Germany: Fluorescent Immunoassay Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 15. Germany: Fluorescent Immunoassay Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 16. UK: Fluorescent Immunoassay Market, by Product Type – Revenue and Forecast to 2028 (USD Million)
Table 17. UK: Fluorescent Immunoassay Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 18. UK: Fluorescent Immunoassay Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 19. France: Fluorescent Immunoassay Market, by Product Type – Revenue and Forecast to 2028 (USD Million)
Table 20. France: Fluorescent Immunoassay Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 21. France: Fluorescent Immunoassay Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 22. Italy: Fluorescent Immunoassay Market, by Product Type – Revenue and Forecast to 2028 (USD Million)
Table 23. Italy: Fluorescent Immunoassay Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 24. Italy: Fluorescent Immunoassay Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 25. Spain: Fluorescent Immunoassay Market, by Product Type – Revenue and Forecast to 2028 (USD Million)
Table 26. Spain: Fluorescent Immunoassay Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 27. Spain: Fluorescent Immunoassay Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 28. Rest of Europe: Fluorescent Immunoassay Market, by Product Type – Revenue and Forecast to 2028 (USD Million)
Table 29. Rest of Europe: Fluorescent Immunoassay Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 30. Rest of Europe: Fluorescent Immunoassay Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 31. Asia-Pacific: Fluorescent Immunoassay Market, by Product Type– Revenue and Forecast to 2028 (USD Million)
Table 32. Asia-Pacific: Fluorescent Immunoassay Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 33. Asia-Pacific: Fluorescent Immunoassay Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 34. China: Fluorescent Immunoassay Market, by Product Type– Revenue and Forecast to 2028 (USD Million)
Table 35. China: Fluorescent Immunoassay Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 36. China: Fluorescent Immunoassay Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 37. Japan: Fluorescent Immunoassay Market, by Product Type– Revenue and Forecast to 2028 (USD Million)
Table 38. Japan: Fluorescent Immunoassay Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 39. Japan: Fluorescent Immunoassay Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 40. India: Fluorescent Immunoassay Market, by Product Type– Revenue and Forecast to 2028 (USD Million)
Table 41. India: Fluorescent Immunoassay Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 42. India: Fluorescent Immunoassay Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 43. South Korea: Fluorescent Immunoassay Market, by Product Type– Revenue and Forecast to 2028 (USD Million)
Table 44. South Korea: Fluorescent Immunoassay Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 45. South Korea: Fluorescent Immunoassay Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 46. Australia: Fluorescent Immunoassay Market, by Product Type– Revenue and Forecast to 2028 (USD Million)
Table 47. Australia: Fluorescent Immunoassay Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 48. Australia: Fluorescent Immunoassay Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 49. Rest of Asia Pacific: Fluorescent Immunoassay Market, by Product Type– Revenue and Forecast to 2028 (USD Million)
Table 50. Rest of Asia Pacific: Fluorescent Immunoassay Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 51. Rest of Asia Pacific: Fluorescent Immunoassay Market, by End User– Revenue and Forecast to 2028 (USD Million)
Table 52. Middle East & Africa Fluorescent Immunoassay Market, by Product Type – Revenue and Forecast to 2028 (USD Million)
Table 53. Middle East & Africa Fluorescent Immunoassay Market, by Application - Revenue and Forecast to 2028 (USD Million)
Table 54. Middle East & Africa Fluorescent Immunoassay Market, by End User - Revenue and Forecast to 2028 (USD Million)
Table 55. Saudi Arabia Fluorescent Immunoassay Market, by Product Type – Revenue and Forecast to 2028 (USD Million)
Table 56. Saudi Arabia Fluorescent Immunoassay Market, by Application - Revenue and Forecast to 2028 (USD Million)
Table 57. Saudi Arabia Fluorescent Immunoassay Market, by End User - Revenue and Forecast to 2028 (USD Million)
Table 58. UAE: Fluorescent Immunoassay Market, by Product Type – Revenue and Forecast to 2028 (USD Million)
Table 59. UAE: Fluorescent Immunoassay Market, by Application - Revenue and Forecast to 2028 (USD Million)
Table 60. UAE: Fluorescent Immunoassay Market, by End User - Revenue and Forecast to 2028 (USD Million)
Table 61. South Africa Fluorescent Immunoassay Market, by Product Type – Revenue and Forecast to 2028 (USD Million)
Table 62. South Africa Fluorescent Immunoassay Market, by Application - Revenue and Forecast to 2028 (USD Million
Table 63. South Africa Fluorescent Immunoassay Market, by End User - Revenue and Forecast to 2028 (USD Million)
Table 64. Rest of Middle East & Africa: Fluorescent Immunoassay Market, by Product Type – Revenue and Forecast to 2028 (USD Million)
Table 65. Rest of Middle East & Africa: Fluorescent Immunoassay Market, by Application - Revenue and Forecast to 2028 (USD Million)
Table 66. Rest of Middle East & Africa: Fluorescent Immunoassay Market, by End User - Revenue and Forecast to 2028 (USD Million)
Table 67. South and Central America: Fluorescent Immunoassay Market, by Product Type – Revenue and Forecast to 2028 (USD Million)
Table 68. South and Central America: Fluorescent Immunoassay Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 69. South and Central America: Fluorescent Immunoassay Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 70. Brazil: Fluorescent Immunoassay Market, by Product Type – Revenue and Forecast to 2028 (USD Million)
Table 71. Brazil: Fluorescent Immunoassay Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 72. Brazil: Fluorescent Immunoassay Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 73. Argentina: Fluorescent Immunoassay Market, by Product Type – Revenue and Forecast to 2028 (USD Million)
Table 74. Argentina: Fluorescent Immunoassay Market, by Application – Revenue and Forecast to 2028 (USD Million)
Argentina: Fluorescent Immunoassay Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 75. Argentina: Fluorescent Immunoassay Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 76. Rest of South and Central America: Fluorescent Immunoassay Market, by Product Type – Revenue and Forecast to 2028 (USD Million)
Table 77. Rest of South and Central America: Fluorescent Immunoassay Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 78. Rest of South and Central America: Fluorescent Immunoassay Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 79. Organic Developments in the Fluorescent Immunoassay Market
Table 80. Inorganic Developments in the Fluorescent Immunoassay Market
Table 81. Glossary of Terms, Fluorescent Immunoassay Market
LIST OF FIGURES
Figure 1. Fluorescent Immunoassay Market Segmentation
Figure 2. Fluorescent Immunoassay Market – By Geography
Figure 3. Fluorescent Immunoassay Market Overview
Figure 4. ELISA by Product Type Held Largest Share of Fluorescent Immunoassay Market
Figure 5. Asia Pacific to Show Significant Growth During Forecast Period
Figure 6. Fluorescent Immunoassay Market, by Geography (USD Million)
Figure 7. Global Fluorescent Immunoassay Market – Leading Country Markets (USD Million)
Figure 8. Global Fluorescent Immunoassay Market, Industry Landscape
Figure 9. North America PEST Analysis
Figure 10. Europe PEST Analysis
Figure 11. Asia Pacific PEST Analysis
Figure 12. Middle East & Africa PEST Analysis
Figure 13. South & Central America PEST Analysis
Figure 14. Global Fluorescent Immunoassay Market Impact Analysis of Driver and Restraints
Figure 15. Global Fluorescent Immunoassay Market – Revenue Forecast And Analysis – 2020- 2028
Figure 16. Global Fluorescent Immunoassay Market – By Geography Forecast and Analysis – 2021- 2028
Figure 17. Global Fluorescent Immunoassay Market – Market Potential Analysis, By Region
Figure 18. Market Share Analysis of Key Players in Global Fluorescent Immunoassay Market
Figure 19. Market Positioning Of Key Players In Global Fluorescent Immunoassay Market
Figure 20. Global Fluorescent Immunoassay Market – Comparative Company Analysis
Figure 21. Global Fluorescent Immunoassay Market – Growth Strategy Analysis
Figure 22. Global Fluorescent Immunoassay Market Share by Product Type - 2021 & 2028 (%)
Figure 23. ELISA: Fluorescent Immunoassay Market Revenue and Forecasts To 2028 (USD Million)
Figure 24. Rapid Lateral Flow Immunoassay: Fluorescent Immunoassay Market Revenue and Forecasts To 2028 (USD Million)
Figure 25. Others: Fluorescent Immunoassay Market Revenue and Forecasts To 2028 (USD Million)
Figure 26. Global Fluorescent Immunoassay Market Share by Application - 2021 & 2028 (%)
Figure 27. Infectious Diseases: Fluorescent Immunoassay Market Revenue and Forecasts To 2028 (USD Million)
Figure 28. Most Prevalent Forms of Cancers Globally, 2020
Figure 29. Oncology: Fluorescent Immunoassay Market Revenue and Forecasts To 2028 (USD Million)
Figure 30. Cardiovascular Disease: Fluorescent Immunoassay Market Revenue and Forecasts To 2028 (USD Million)
Figure 31. Others: Fluorescent Immunoassay Market Revenue and Forecasts To 2028 (USD Million)
Figure 32. Global Fluorescent Immunoassay Market Share by End User - 2021 & 2028 (%)
Figure 33. Hospitals & Clinics: Fluorescent Immunoassay Market Revenue and Forecasts To 2028 (USD Million)
Figure 34. Diagnostic Centers: Fluorescent Immunoassay Market Revenue and Forecasts To 2028 (USD Million)
Figure 35. Pharmaceutical & Biotechnology Companies: Fluorescent Immunoassay Market Revenue and Forecasts To 2028 (USD Million)
Figure 36. Academic & Research Institutes: Fluorescent Immunoassay Market Revenue and Forecasts To 2028 (USD Million)
Figure 37. Others: Fluorescent Immunoassay Market Revenue and Forecasts To 2028 (USD Million)
Figure 38. North America Fluorescent Immunoassay Market Revenue Overview, by Country, 2021 (US$ Million)
Figure 39. North America Fluorescent Immunoassay Market Revenue and Forecasts to 2028 (USD Million)
Figure 40. North America Fluorescent Immunoassay Market Revenue and Forecasts to 2028, By Country (%)
Figure 41. US: Fluorescent Immunoassay Market Revenue and Forecasts to 2028 (USD Million)
Figure 42. Canada: Fluorescent Immunoassay Market Revenue and Forecasts to 2028 (USD Million)
Figure 43. Mexico: Fluorescent Immunoassay Market Revenue and Forecasts to 2028 (USD Million)
Figure 44. Europe Fluorescent Immunoassay Market Revenue Overview, by Country, 2021 (US$ Million)
Figure 45. Europe Fluorescent Immunoassay Market Revenue and Forecasts to 2028 (USD Million)
Figure 46. Europe Fluorescent Immunoassay Market Revenue and Forecasts to 2028, By Country (%)
Figure 47. Germany: Fluorescent Immunoassay Market Revenue and Forecasts to 2028 (USD Million)
Figure 48. UK: Fluorescent Immunoassay Market Revenue and Forecasts to 2028 (USD Million)
Figure 49. France: Fluorescent Immunoassay Market Revenue and Forecasts to 2028 (USD Million)
Figure 50. Italy: Fluorescent Immunoassay Market Revenue and Forecasts to 2028 (USD Million)
Figure 51. Spain: Fluorescent Immunoassay Market Revenue and Forecasts to 2028 (USD Million)
Figure 52. Rest of Europe: Fluorescent Immunoassay Market Revenue and Forecasts to 2028 (USD Million)
Figure 53. Asia Pacific: Fluorescent Immunoassay Market, by Key Country – Revenue (2021) (USD Million)
Figure 54. Asia Pacific Fluorescent Immunoassay Market Revenue and Forecast to 2028 (USD Million)
Figure 55. Asia Pacific: Fluorescent Immunoassay Market, by Country, 2021 & 2028 (%)
Figure 56. China: Fluorescent Immunoassay Market – Revenue and Forecast to 2028 (USD Million)
Figure 57. Japan: Fluorescent Immunoassay Market – Revenue and Forecast to 2028 (USD Million)
Figure 58. India: Fluorescent Immunoassay Market – Revenue and Forecast to 2028 (USD Million)
Figure 59. South Korea: Fluorescent Immunoassay Market – Revenue and Forecast to 2028 (USD Million)
Figure 60. Australia: Fluorescent Immunoassay Market – Revenue and Forecast to 2028 (USD Million)
Figure 61. Rest of Asia Pacific: Fluorescent Immunoassay Market – Revenue and Forecast to 2028 (USD Million)
Figure 62. Middle East & Africa: Fluorescent Immunoassay Market, by Key Country – Revenue (2021) (USD Million)
Figure 63. Middle East & Africa Fluorescent Immunoassay Market Revenue and Forecast to 2028 (USD Million)
Figure 64. Middle East & Africa: Fluorescent Immunoassay Market, by Country, 2021 & 2028 (%)
Figure 65. Saudi Arabia: Fluorescent Immunoassay Market – Revenue and Forecast to 2028 (USD Million)
Figure 66. UAE: Fluorescent Immunoassay Market – Revenue and Forecast to 2028 (USD Million)
Figure 67. South Africa: Fluorescent Immunoassay Market – Revenue and Forecast to 2028 (USD Million)
Figure 68. Rest of Middle East and Africa: Fluorescent Immunoassay Market – Revenue and Forecast to 2028 (USD Million)
Figure 69. South and Central America Fluorescent Immunoassay Market Revenue Overview, by Country, 2021 (US$ Million)
Figure 70. South and Central America Fluorescent Immunoassay Market Revenue and Forecasts to 2028 (USD Million)
Figure 71. South and Central America Fluorescent Immunoassay Market Revenue and Forecasts to 2028, By Country (%)
Figure 72. Brazil: Fluorescent Immunoassay Market Revenue and Forecasts to 2028 (USD Million)
Figure 73. Argentina Fluorescent Immunoassay Market Revenue and Forecasts to 2028 (USD Million)
Figure 74. Rest of South and Central America: Fluorescent Immunoassay Market– Revenue and Forecast to 2028 (USD Mn)
Figure 75. Impact of COVID-19 Pandemic in North American Country Markets
Figure 76. Impact of COVID-19 Pandemic in European Country Markets
Figure 77. Impact of COVID-19 Pandemic in Asia Pacific Country Markets
Figure 78. Impact of COVID-19 Pandemic in Middle East & Africa Country Markets
Figure 79. Impact of COVID-19 Pandemic in South & Central America Country Markets
Figure 80. Growth Strategies in the Fluorescent Immunoassay Market (%)
The List of Companies - Fluorescent Immunoassay Market
- Thermo Fisher Scientific
- Abbott Laboratories
- Ortho Clinical Diagnostics
- BD
- F. Hoffmann La Roche
- Danaher
- bioMérieux SA
- Siemens AG
- Sysmex
- Quidel Corporation
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Fluorescent Immunoassay Market
May 2022
Bioprocessing Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Instruments, and Consumables and Accessories), Scale of Operation (Commercial Operations and Clinical Operations), Process (Downstream Bioprocess and Upstream Bioprocess), Application (Monoclonal Antibodies, Vaccines, Recombinant Protein, Cell and Gene Therapy, and Others), End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
May 2022
Bioproduction Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product (Biologics and Biosimilars, Vaccines, Cell and Gene Therapies, Nucleic Acid Therapeutics, and Others), Application (Rheumatoid Arthritis, Hematological Disorders, Cancer, Diabetes, Cardiovascular Diseases, and Others), Equipment (Upstream Equipment, Downstream Equipment, Bioreactors, and Consumables and Accessories), End User (Biopharmaceutical Companies, Contract Manufacturing Organizations, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
May 2022
ELISA Diagnostic Test Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Adoption (Human and Veterinary), Test Type (Sandwich ELISA, Indirect ELISA, Competitive ELISA, and Multiple & Portable ELISA), Application (Autoimmune Diseases, Infectious Diseases, Cancer Diagnosis, Protein Quantification, and Others), End User (Hospitals & Diagnostic Centers, Pharmaceutical & Biotechnology Companies, Veterinary Hospitals & Diagnostic Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
May 2022
Swine Diagnostics Market
Size and Forecasts (2022 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product Type [Immunoassays Kits, PCR Kits, Hemagglutination Inhibition (HI), and Others], Sample Type (Blood, Oral Fluids, Nasal Swabs, Tissue Samples, and Others), Disease [African Swine Fever (ASF)/Classical Swine Fever (CSF), Respiratory Diseases, Porcine Circovirus, Porcine Epidemic Diarrhea, Swine Dysentery, and Others], End User (Veterinary Hospitals, Veterinary Clinics, and Other End Users), and Geography
May 2022
Microbial Identification Methods Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Method (Genotypic, Phenotypic, and Proteotypic), Type (Bacterial Identification System, Microbial Enumeration System, Bacterial Resistance Identification Systems, Microbiology Analyzer, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and Latin America)
May 2022
Biopharmaceuticals Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Monoclonal Antibodies, Recombinant Vaccines, Conventional Vaccines, Recombinant Growth Factors, Purified Proteins, Recombinant Proteins, Recombinant Hormones, Recombinant Enzymes, Cell & Gene Therapies, Cytokines/Interferon/Interleukins, and Others) and Application (Oncology, Inflammatory & Infectious Disease, Autoimmune Disorders, Metabolic Disorders, Hormonal Disorders & Growth Failure, Cardiovascular Diseases, Neurological Diseases, and Others)
May 2022
GMP Cell Therapy Consumables Market
Forecast to 2028 - COVID-19 Impact and Global Analysis by Product (Kits, Reagents/Molecular Biology Reagents, Growth Factors/Cytokines and Interleukins, and Others), Cell Therapy (NK Cell Therapy, Stem Cell Therapy, T-Cell Therapy, and Others), Process (Cell Collection and Characterization/Sorting and Separation, Cell Culture and Expansion/Preparation, Cryopreservation, Cell Processing and Formulation, Cell Isolation and Activation, Cell Distribution/Handling, Process Monitoring and Control/Readministration/Quality Assurance, and Others), and End Use (Clinical, Commercial, and Research)
May 2022